Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Interventional × Calibration × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Insulin Resistance 1

Interventions

Cyclophosphamide 2031 Radiotherapy 1843 Cisplatin 1806 Carboplatin 1524 Gemcitabine 1423 Paclitaxel 1284 Bevacizumab 1257 Docetaxel 1199 pembrolizumab 1192 Oxaliplatin 1148 Capecitabine 1131 Fluorouracil 1056 Dexamethasone 967 Rituximab 913 Nivolumab 904 Magnetic Resonance Spectroscopy 843 Etoposide 835 Doxorubicin 822 Drug Therapy 779 Irinotecan 773 Radiosurgery 768 Cytarabine 732 fludarabine 701 Leucovorin 671 Lenalidomide 606 fludarabine phosphate 561 Temozolomide 551 Filgrastim 539 Radiation 537 Cetuximab 534

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07483723 2026-03-19

PROGLYSOPK

Centre Hospitalier Universitaire, Amiens

Phase NA Recruiting

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡